COVID-19 Impact on Global Traumatic Brain Injury Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 134 pages | ID: CC240594AE1AEN
QYResearch

Abstracts

This report focuses on the global Traumatic Brain Injury Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Traumatic Brain Injury Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• SFC Fluidics LLC
• Banayan Biomarkers Inc.
• BHR Pharma LLC
• Cerora Inc.
• ElMindA Ltd.
• Grace Laboratories LLC
• KeyNeurotek Pharmaceuticals AG
• Luoxis Diagnostics
• Neuro Assessment Systems
• Neurovive Pharmaceuticals AB
• Oxygen Biotherapeutics Inc.
• Phlogistix LLC
• Neurohealing Pharmaceuticals
• Neuren Pharmaceuticals Ltd.
• Remedy Pharmaceuticals Inc.
• Biodirection Inc.
• Brainscope Company Inc.
• TEVA Pharmaceutical Industries Ltd.
• Vasopharm

Market segment by Type, the product can be split into

• Acetylcholinesterase Inhibitors
• Erythropoietin
• Growth Hormone
• Stem Cells
• Others

Market segment by Application, split into

• Local TBI
• Open TBI
• Closed TBI
• Diffuse TBI
• Primary TBI
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Traumatic Brain Injury Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Traumatic Brain Injury Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Traumatic Brain Injury Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Traumatic Brain Injury Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Traumatic Brain Injury Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Acetylcholinesterase Inhibitors
  1.4.3 Erythropoietin
  1.4.4 Growth Hormone
  1.4.5 Stem Cells
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Traumatic Brain Injury Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Local TBI
  1.5.3 Open TBI
  1.5.4 Closed TBI
  1.5.5 Diffuse TBI
  1.5.6 Primary TBI
  1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Traumatic Brain Injury Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Traumatic Brain Injury Therapeutics Industry
    1.6.1.1 Traumatic Brain Injury Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Traumatic Brain Injury Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Traumatic Brain Injury Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Traumatic Brain Injury Therapeutics Market Perspective (2015-2026)
2.2 Traumatic Brain Injury Therapeutics Growth Trends by Regions
  2.2.1 Traumatic Brain Injury Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Traumatic Brain Injury Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Traumatic Brain Injury Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Traumatic Brain Injury Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Traumatic Brain Injury Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Traumatic Brain Injury Therapeutics Players by Market Size
  3.1.1 Global Top Traumatic Brain Injury Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Traumatic Brain Injury Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Traumatic Brain Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Traumatic Brain Injury Therapeutics Market Concentration Ratio
  3.2.1 Global Traumatic Brain Injury Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Traumatic Brain Injury Therapeutics Revenue in 2019
3.3 Traumatic Brain Injury Therapeutics Key Players Head office and Area Served
3.4 Key Players Traumatic Brain Injury Therapeutics Product Solution and Service
3.5 Date of Enter into Traumatic Brain Injury Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Traumatic Brain Injury Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Traumatic Brain Injury Therapeutics Forecasted Market Size by Type (2021-2026)

5 TRAUMATIC BRAIN INJURY THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)
5.2 Global Traumatic Brain Injury Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Traumatic Brain Injury Therapeutics Market Size (2015-2020)
6.2 Traumatic Brain Injury Therapeutics Key Players in North America (2019-2020)
6.3 North America Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020)
6.4 North America Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Traumatic Brain Injury Therapeutics Market Size (2015-2020)
7.2 Traumatic Brain Injury Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020)
7.4 Europe Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Traumatic Brain Injury Therapeutics Market Size (2015-2020)
8.2 Traumatic Brain Injury Therapeutics Key Players in China (2019-2020)
8.3 China Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020)
8.4 China Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Traumatic Brain Injury Therapeutics Market Size (2015-2020)
9.2 Traumatic Brain Injury Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020)
9.4 Japan Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Traumatic Brain Injury Therapeutics Market Size (2015-2020)
10.2 Traumatic Brain Injury Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Traumatic Brain Injury Therapeutics Market Size (2015-2020)
11.2 Traumatic Brain Injury Therapeutics Key Players in India (2019-2020)
11.3 India Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020)
11.4 India Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Traumatic Brain Injury Therapeutics Market Size (2015-2020)
12.2 Traumatic Brain Injury Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 SFC Fluidics LLC
  13.1.1 SFC Fluidics LLC Company Details
  13.1.2 SFC Fluidics LLC Business Overview and Its Total Revenue
  13.1.3 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Introduction
  13.1.4 SFC Fluidics LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020))
  13.1.5 SFC Fluidics LLC Recent Development
13.2 Banayan Biomarkers Inc.
  13.2.1 Banayan Biomarkers Inc. Company Details
  13.2.2 Banayan Biomarkers Inc. Business Overview and Its Total Revenue
  13.2.3 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Introduction
  13.2.4 Banayan Biomarkers Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.2.5 Banayan Biomarkers Inc. Recent Development
13.3 BHR Pharma LLC
  13.3.1 BHR Pharma LLC Company Details
  13.3.2 BHR Pharma LLC Business Overview and Its Total Revenue
  13.3.3 BHR Pharma LLC Traumatic Brain Injury Therapeutics Introduction
  13.3.4 BHR Pharma LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.3.5 BHR Pharma LLC Recent Development
13.4 Cerora Inc.
  13.4.1 Cerora Inc. Company Details
  13.4.2 Cerora Inc. Business Overview and Its Total Revenue
  13.4.3 Cerora Inc. Traumatic Brain Injury Therapeutics Introduction
  13.4.4 Cerora Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.4.5 Cerora Inc. Recent Development
13.5 ElMindA Ltd.
  13.5.1 ElMindA Ltd. Company Details
  13.5.2 ElMindA Ltd. Business Overview and Its Total Revenue
  13.5.3 ElMindA Ltd. Traumatic Brain Injury Therapeutics Introduction
  13.5.4 ElMindA Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.5.5 ElMindA Ltd. Recent Development
13.6 Grace Laboratories LLC
  13.6.1 Grace Laboratories LLC Company Details
  13.6.2 Grace Laboratories LLC Business Overview and Its Total Revenue
  13.6.3 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Introduction
  13.6.4 Grace Laboratories LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.6.5 Grace Laboratories LLC Recent Development
13.7 KeyNeurotek Pharmaceuticals AG
  13.7.1 KeyNeurotek Pharmaceuticals AG Company Details
  13.7.2 KeyNeurotek Pharmaceuticals AG Business Overview and Its Total Revenue
  13.7.3 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Introduction
  13.7.4 KeyNeurotek Pharmaceuticals AG Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.7.5 KeyNeurotek Pharmaceuticals AG Recent Development
13.8 Luoxis Diagnostics
  13.8.1 Luoxis Diagnostics Company Details
  13.8.2 Luoxis Diagnostics Business Overview and Its Total Revenue
  13.8.3 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Introduction
  13.8.4 Luoxis Diagnostics Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.8.5 Luoxis Diagnostics Recent Development
13.9 Neuro Assessment Systems
  13.9.1 Neuro Assessment Systems Company Details
  13.9.2 Neuro Assessment Systems Business Overview and Its Total Revenue
  13.9.3 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Introduction
  13.9.4 Neuro Assessment Systems Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.9.5 Neuro Assessment Systems Recent Development
13.10 Neurovive Pharmaceuticals AB
  13.10.1 Neurovive Pharmaceuticals AB Company Details
  13.10.2 Neurovive Pharmaceuticals AB Business Overview and Its Total Revenue
  13.10.3 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Introduction
  13.10.4 Neurovive Pharmaceuticals AB Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  13.10.5 Neurovive Pharmaceuticals AB Recent Development
13.11 Oxygen Biotherapeutics Inc.
  10.11.1 Oxygen Biotherapeutics Inc. Company Details
  10.11.2 Oxygen Biotherapeutics Inc. Business Overview and Its Total Revenue
  10.11.3 Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Introduction
  10.11.4 Oxygen Biotherapeutics Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.11.5 Oxygen Biotherapeutics Inc. Recent Development
13.12 Phlogistix LLC
  10.12.1 Phlogistix LLC Company Details
  10.12.2 Phlogistix LLC Business Overview and Its Total Revenue
  10.12.3 Phlogistix LLC Traumatic Brain Injury Therapeutics Introduction
  10.12.4 Phlogistix LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.12.5 Phlogistix LLC Recent Development
13.13 Neurohealing Pharmaceuticals
  10.13.1 Neurohealing Pharmaceuticals Company Details
  10.13.2 Neurohealing Pharmaceuticals Business Overview and Its Total Revenue
  10.13.3 Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Introduction
  10.13.4 Neurohealing Pharmaceuticals Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.13.5 Neurohealing Pharmaceuticals Recent Development
13.14 Neuren Pharmaceuticals Ltd.
  10.14.1 Neuren Pharmaceuticals Ltd. Company Details
  10.14.2 Neuren Pharmaceuticals Ltd. Business Overview and Its Total Revenue
  10.14.3 Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Introduction
  10.14.4 Neuren Pharmaceuticals Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.14.5 Neuren Pharmaceuticals Ltd. Recent Development
13.15 Remedy Pharmaceuticals Inc.
  10.15.1 Remedy Pharmaceuticals Inc. Company Details
  10.15.2 Remedy Pharmaceuticals Inc. Business Overview and Its Total Revenue
  10.15.3 Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Introduction
  10.15.4 Remedy Pharmaceuticals Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.15.5 Remedy Pharmaceuticals Inc. Recent Development
13.16 Biodirection Inc.
  10.16.1 Biodirection Inc. Company Details
  10.16.2 Biodirection Inc. Business Overview and Its Total Revenue
  10.16.3 Biodirection Inc. Traumatic Brain Injury Therapeutics Introduction
  10.16.4 Biodirection Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.16.5 Biodirection Inc. Recent Development
13.17 Brainscope Company Inc.
  10.17.1 Brainscope Company Inc. Company Details
  10.17.2 Brainscope Company Inc. Business Overview and Its Total Revenue
  10.17.3 Brainscope Company Inc. Traumatic Brain Injury Therapeutics Introduction
  10.17.4 Brainscope Company Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.17.5 Brainscope Company Inc. Recent Development
13.18 TEVA Pharmaceutical Industries Ltd.
  10.18.1 TEVA Pharmaceutical Industries Ltd. Company Details
  10.18.2 TEVA Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  10.18.3 TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Introduction
  10.18.4 TEVA Pharmaceutical Industries Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.18.5 TEVA Pharmaceutical Industries Ltd. Recent Development
13.19 Vasopharm
  10.19.1 Vasopharm Company Details
  10.19.2 Vasopharm Business Overview and Its Total Revenue
  10.19.3 Vasopharm Traumatic Brain Injury Therapeutics Introduction
  10.19.4 Vasopharm Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020)
  10.19.5 Vasopharm Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Traumatic Brain Injury Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Traumatic Brain Injury Therapeutics Revenue
Table 3. Ranking of Global Top Traumatic Brain Injury Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Traumatic Brain Injury Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acetylcholinesterase Inhibitors
Table 6. Key Players of Erythropoietin
Table 7. Key Players of Growth Hormone
Table 8. Key Players of Stem Cells
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Traumatic Brain Injury Therapeutics Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Traumatic Brain Injury Therapeutics Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Traumatic Brain Injury Therapeutics Players to Combat Covid-19 Impact
Table 15. Global Traumatic Brain Injury Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Traumatic Brain Injury Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Traumatic Brain Injury Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Traumatic Brain Injury Therapeutics Market Share by Regions (2015-2020)
Table 19. Global Traumatic Brain Injury Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Traumatic Brain Injury Therapeutics Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Traumatic Brain Injury Therapeutics Market Growth Strategy
Table 25. Main Points Interviewed from Key Traumatic Brain Injury Therapeutics Players
Table 26. Global Traumatic Brain Injury Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 27. Global Traumatic Brain Injury Therapeutics Market Share by Players (2015-2020)
Table 28. Global Top Traumatic Brain Injury Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Traumatic Brain Injury Therapeutics as of 2019)
Table 29. Global Traumatic Brain Injury Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Traumatic Brain Injury Therapeutics Product Solution and Service
Table 32. Date of Enter into Traumatic Brain Injury Therapeutics Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. Global Traumatic Brain Injury Therapeutics Market Size Share by Type (2015-2020)
Table 36. Global Traumatic Brain Injury Therapeutics Revenue Market Share by Type (2021-2026)
Table 37. Global Traumatic Brain Injury Therapeutics Market Size Share by Application (2015-2020)
Table 38. Global Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. Global Traumatic Brain Injury Therapeutics Market Size Share by Application (2021-2026)
Table 40. North America Key Players Traumatic Brain Injury Therapeutics Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Traumatic Brain Injury Therapeutics Market Share (2019-2020)
Table 42. North America Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. North America Traumatic Brain Injury Therapeutics Market Share by Type (2015-2020)
Table 44. North America Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. North America Traumatic Brain Injury Therapeutics Market Share by Application (2015-2020)
Table 46. Europe Key Players Traumatic Brain Injury Therapeutics Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Traumatic Brain Injury Therapeutics Market Share (2019-2020)
Table 48. Europe Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Traumatic Brain Injury Therapeutics Market Share by Type (2015-2020)
Table 50. Europe Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Traumatic Brain Injury Therapeutics Market Share by Application (2015-2020)
Table 52. China Key Players Traumatic Brain Injury Therapeutics Revenue (2019-2020) (Million US$)
Table 53. China Key Players Traumatic Brain Injury Therapeutics Market Share (2019-2020)
Table 54. China Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. China Traumatic Brain Injury Therapeutics Market Share by Type (2015-2020)
Table 56. China Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. China Traumatic Brain Injury Therapeutics Market Share by Application (2015-2020)
Table 58. Japan Key Players Traumatic Brain Injury Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Traumatic Brain Injury Therapeutics Market Share (2019-2020)
Table 60. Japan Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Traumatic Brain Injury Therapeutics Market Share by Type (2015-2020)
Table 62. Japan Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Traumatic Brain Injury Therapeutics Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Traumatic Brain Injury Therapeutics Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Traumatic Brain Injury Therapeutics Market Share (2019-2020)
Table 66. Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Traumatic Brain Injury Therapeutics Market Share by Type (2015-2020)
Table 68. Southeast Asia Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Traumatic Brain Injury Therapeutics Market Share by Application (2015-2020)
Table 70. India Key Players Traumatic Brain Injury Therapeutics Revenue (2019-2020) (Million US$)
Table 71. India Key Players Traumatic Brain Injury Therapeutics Market Share (2019-2020)
Table 72. India Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. India Traumatic Brain Injury Therapeutics Market Share by Type (2015-2020)
Table 74. India Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. India Traumatic Brain Injury Therapeutics Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Traumatic Brain Injury Therapeutics Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Traumatic Brain Injury Therapeutics Market Share (2019-2020)
Table 78. Central & South America Traumatic Brain Injury Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Traumatic Brain Injury Therapeutics Market Share by Type (2015-2020)
Table 80. Central & South America Traumatic Brain Injury Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Traumatic Brain Injury Therapeutics Market Share by Application (2015-2020)
Table 82. SFC Fluidics LLC Company Details
Table 83. SFC Fluidics LLC Business Overview
Table 84. SFC Fluidics LLC Product
Table 85. SFC Fluidics LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 86. SFC Fluidics LLC Recent Development
Table 87. Banayan Biomarkers Inc. Company Details
Table 88. Banayan Biomarkers Inc. Business Overview
Table 89. Banayan Biomarkers Inc. Product
Table 90. Banayan Biomarkers Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 91. Banayan Biomarkers Inc. Recent Development
Table 92. BHR Pharma LLC Company Details
Table 93. BHR Pharma LLC Business Overview
Table 94. BHR Pharma LLC Product
Table 95. BHR Pharma LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 96. BHR Pharma LLC Recent Development
Table 97. Cerora Inc. Company Details
Table 98. Cerora Inc. Business Overview
Table 99. Cerora Inc. Product
Table 100. Cerora Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 101. Cerora Inc. Recent Development
Table 102. ElMindA Ltd. Company Details
Table 103. ElMindA Ltd. Business Overview
Table 104. ElMindA Ltd. Product
Table 105. ElMindA Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 106. ElMindA Ltd. Recent Development
Table 107. Grace Laboratories LLC Company Details
Table 108. Grace Laboratories LLC Business Overview
Table 109. Grace Laboratories LLC Product
Table 110. Grace Laboratories LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 111. Grace Laboratories LLC Recent Development
Table 112. KeyNeurotek Pharmaceuticals AG Company Details
Table 113. KeyNeurotek Pharmaceuticals AG Business Overview
Table 114. KeyNeurotek Pharmaceuticals AG Product
Table 115. KeyNeurotek Pharmaceuticals AG Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 116. KeyNeurotek Pharmaceuticals AG Recent Development
Table 117. Luoxis Diagnostics Business Overview
Table 118. Luoxis Diagnostics Product
Table 119. Luoxis Diagnostics Company Details
Table 120. Luoxis Diagnostics Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 121. Luoxis Diagnostics Recent Development
Table 122. Neuro Assessment Systems Company Details
Table 123. Neuro Assessment Systems Business Overview
Table 124. Neuro Assessment Systems Product
Table 125. Neuro Assessment Systems Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 126. Neuro Assessment Systems Recent Development
Table 127. Neurovive Pharmaceuticals AB Company Details
Table 128. Neurovive Pharmaceuticals AB Business Overview
Table 129. Neurovive Pharmaceuticals AB Product
Table 130. Neurovive Pharmaceuticals AB Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 131. Neurovive Pharmaceuticals AB Recent Development
Table 132. Oxygen Biotherapeutics Inc. Company Details
Table 133. Oxygen Biotherapeutics Inc. Business Overview
Table 134. Oxygen Biotherapeutics Inc. Product
Table 135. Oxygen Biotherapeutics Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 136. Oxygen Biotherapeutics Inc. Recent Development
Table 137. Phlogistix LLC Company Details
Table 138. Phlogistix LLC Business Overview
Table 139. Phlogistix LLC Product
Table 140. Phlogistix LLC Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 141. Phlogistix LLC Recent Development
Table 142. Neurohealing Pharmaceuticals Company Details
Table 143. Neurohealing Pharmaceuticals Business Overview
Table 144. Neurohealing Pharmaceuticals Product
Table 145. Neurohealing Pharmaceuticals Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 146. Neurohealing Pharmaceuticals Recent Development
Table 147. Neuren Pharmaceuticals Ltd. Company Details
Table 148. Neuren Pharmaceuticals Ltd. Business Overview
Table 149. Neuren Pharmaceuticals Ltd. Product
Table 150. Neuren Pharmaceuticals Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 151. Neuren Pharmaceuticals Ltd. Recent Development
Table 152. Remedy Pharmaceuticals Inc. Company Details
Table 153. Remedy Pharmaceuticals Inc. Business Overview
Table 154. Remedy Pharmaceuticals Inc. Product
Table 155. Remedy Pharmaceuticals Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 156. Remedy Pharmaceuticals Inc. Recent Development
Table 157. Biodirection Inc. Company Details
Table 158. Biodirection Inc. Business Overview
Table 159. Biodirection Inc. Product
Table 160. Biodirection Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 161. Biodirection Inc. Recent Development
Table 162. Brainscope Company Inc. Company Details
Table 163. Brainscope Company Inc. Business Overview
Table 164. Brainscope Company Inc. Product
Table 165. Brainscope Company Inc. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 166. Brainscope Company Inc. Recent Development
Table 167. TEVA Pharmaceutical Industries Ltd. Company Details
Table 168. TEVA Pharmaceutical Industries Ltd. Business Overview
Table 169. TEVA Pharmaceutical Industries Ltd. Product
Table 170. TEVA Pharmaceutical Industries Ltd. Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 171. TEVA Pharmaceutical Industries Ltd. Recent Development
Table 172. Vasopharm Company Details
Table 173. Vasopharm Business Overview
Table 174. Vasopharm Product
Table 175. Vasopharm Revenue in Traumatic Brain Injury Therapeutics Business (2015-2020) (Million US$)
Table 176. Vasopharm Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Traumatic Brain Injury Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Acetylcholinesterase Inhibitors Features
Figure 3. Erythropoietin Features
Figure 4. Growth Hormone Features
Figure 5. Stem Cells Features
Figure 6. Others Features
Figure 7. Global Traumatic Brain Injury Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Local TBI Case Studies
Figure 9. Open TBI Case Studies
Figure 10. Closed TBI Case Studies
Figure 11. Diffuse TBI Case Studies
Figure 12. Primary TBI Case Studies
Figure 13. Others Case Studies
Figure 14. Traumatic Brain Injury Therapeutics Report Years Considered
Figure 15. Global Traumatic Brain Injury Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Traumatic Brain Injury Therapeutics Market Share by Regions: 2020 VS 2026
Figure 17. Global Traumatic Brain Injury Therapeutics Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Traumatic Brain Injury Therapeutics Market Share by Players in 2019
Figure 20. Global Top Traumatic Brain Injury Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Traumatic Brain Injury Therapeutics as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Traumatic Brain Injury Therapeutics Revenue in 2019
Figure 22. North America Traumatic Brain Injury Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Traumatic Brain Injury Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Traumatic Brain Injury Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Traumatic Brain Injury Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Traumatic Brain Injury Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Traumatic Brain Injury Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Traumatic Brain Injury Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. SFC Fluidics LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. SFC Fluidics LLC Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 31. Banayan Biomarkers Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Banayan Biomarkers Inc. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 33. BHR Pharma LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. BHR Pharma LLC Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 35. Cerora Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Cerora Inc. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 37. ElMindA Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ElMindA Ltd. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 39. Grace Laboratories LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Grace Laboratories LLC Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 41. KeyNeurotek Pharmaceuticals AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. KeyNeurotek Pharmaceuticals AG Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 43. Luoxis Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Luoxis Diagnostics Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 45. Neuro Assessment Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Neuro Assessment Systems Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 47. Neurovive Pharmaceuticals AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Neurovive Pharmaceuticals AB Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 49. Oxygen Biotherapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Oxygen Biotherapeutics Inc. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 51. Phlogistix LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Phlogistix LLC Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 53. Neurohealing Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Neurohealing Pharmaceuticals Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 55. Neuren Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Neuren Pharmaceuticals Ltd. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 57. Remedy Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Remedy Pharmaceuticals Inc. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 59. Biodirection Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Biodirection Inc. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 61. Brainscope Company Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Brainscope Company Inc. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 63. TEVA Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. TEVA Pharmaceutical Industries Ltd. Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 65. Vasopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Vasopharm Revenue Growth Rate in Traumatic Brain Injury Therapeutics Business (2015-2020)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed